Skip to main content

and
  1. Article

    Open Access

    Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

    Thomas Burmeister, Aeint-Steffen Ströh, Britta Kehden, Heiko Trautmann in Leukemia (2024)

  2. Article

    Open Access

    Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

    In contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are less well defined in T-lineage ALL. Comprehensive studies on molecular T-ALL subgroups have been predominantly perfor...

    Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann in Leukemia (2024)

  3. Article

    Open Access

    Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment

    The translocation t(1;19)(q23;p13) with the resulting chimeric TCF3::PBX1 gene is the third most prevalent recurrent chromosomal translocation in acute lymphoblastic leukemia and accounts for 3–5% of cases. The m...

    Thomas Burmeister, Daniela Gröger, Nicola Gökbuget, Bernd Spriewald in Scientific Reports (2023)

  4. Article

    Open Access

    FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling

    FAT atypical cadherin 1 (FAT1), a transmembrane protein, is frequently mutated in various cancer types and has been described as context-dependent tumor suppressor or oncogene. The FAT1 gene is mutated in 12–16% ...

    Sven Liebig, Martin Neumann, Patricia Silva, Jutta Ortiz-Tanchez in Scientific Reports (2023)

  5. Article

    Open Access

    Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

    While survival has improved for Burkitt lymphoma patients, potential differences in outcome between pediatric and adult patients remain unclear. In both age groups, survival remains poor at relapse. Therefore,...

    Birgit Burkhardt, Ulf Michgehl, Jonas Rohde, Tabea Erdmann in Nature Communications (2022)

  6. No Access

    Article

    PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

    Chromosomal rearrangements and specific aneuploidy patterns are initiating events and define subgroups in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here we analyzed 250 BCP-ALL cases and identif...

    Lorenz Bastian, Michael P. Schroeder, Cornelia Eckert, Cornelia Schlee in Leukemia (2019)

  7. Article

    Open Access

    Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

    Recent efforts reclassified B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) into more refined subtypes. Nevertheless, outcomes of relapsed BCP-ALL remain unsatisfactory, particularly in adult patients ...

    Michael P. Schroeder, Lorenz Bastian, Cornelia Eckert in Scientific Reports (2019)

  8. Article

    Open Access

    Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia

    Long non-coding RNAs (lncRNAs) have emerged as a novel class of RNA due to its diverse mechanism in cancer development and progression. However, the role and expression pattern of lncRNAs in molecular subtypes...

    Alva Rani James, Michael P. Schroeder, Martin Neumann in Journal of Hematology & Oncology (2019)

  9. No Access

    Article

    BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features

    BCR-ABL-positive acute myeloid leukemia (AML) is a rare subtype of AML that is now included as a provisional entity in the 2016 revised WHO classification of myeloid malignancies. Since a...

    Nina Rosa Neuendorff, Thomas Burmeister, Bernd Dörken in Annals of Hematology (2016)

  10. No Access

    Article

    Rapid and Sensitive Detection of Calreticulin Type 1 and 2 Mutations by Real-Time Quantitative PCR

    The majority of patients with JAK2 V617F-negative essential thrombocythemia or primary myelofibrosis harbor mutations involving the calreticulin (CALR) gene. These mutations are located in CALR exon 9 and lead to...

    Michael Zinke, Vanasa Nageswaran, Richard Reinhardt in Molecular Diagnosis & Therapy (2015)

  11. No Access

    Article

    Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia

    The European LeukemiaNet (ELN) classification is widely accepted for risk stratification of patients with acute myeloid leukemia (AML). In order to establish immunophenotypic features that predict prognosis, t...

    Tanja Schneider, Anne Flörcken, Anju Singh, Seval Türkmen in Annals of Hematology (2015)

  12. No Access

    Article

    Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization

    Acute leukemias of ambiguous lineage represent a heterogeneous group of rare, poorly characterized leukemias with adverse outcome. No larger studies have yet performed a combined approach of molecular and clin...

    Sandra Heesch, Martin Neumann, Stefan Schwartz, Isabelle Bartram in Annals of Hematology (2013)

  13. Article

    Open Access

    Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse

    This report describes the clinical courses of two acute myeloid leukemia patients. Both had MLL translocations, the first a t(10;11)(p11.2;q23) with MLL-AF10 and the second a t(11;19)(q23;p13.1) with MLL-ELL fusi...

    Thomas Burmeister, Mara Molkentin, Claus Meyer in Experimental Hematology & Oncology (2012)

  14. No Access

    Article

    Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation

    Extramedullary relapses after allogeneic stem cell transplantation, especially within the central nervous system (CNS), are not only difficult to treat but also associated with poor outcome. Although the graft...

    Martin Neumann, Igor W. Blau, Thomas Burmeister in Annals of Hematology (2011)

  15. No Access

    Article

    Melting Point Assay for the JAK2 V617F Mutation, Comparison with Amplification Refractory Mutation System (ARMS) in Diagnostic Samples, and Implications for Daily Routine

    Background: Reliable detection of the JAK2 V617F mutation is a major criterion in the diagnosis of BCR/ABL-negative myeloproliferative neoplasms such as polycythemia vera, essential thrombocythem...

    Dr Sebastian Ochsenreither, Mark Reinwald, Eckhard Thiel in Molecular Diagnosis & Therapy (2010)

  16. Article

    Open Access

    No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms

    The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of t...

    Thomas Burmeister, Stefan Schwartz, Michael Hummel, Dieter Hoelzer in Retrovirology (2007)

  17. No Access

    Article

    Molecular genetics in acute and chronic leukemias

    The application of molecular biological techniques in malignant hematologic diseases, particularly leukemias, has led to a rapid increase in knowledge and a deeper insight into the pathobiology of these disea...

    Thomas Burmeister, Eckhard Thiel in Journal of Cancer Research and Clinical Oncology (2001)